Agios Pharm (AGIO) Misses Q2 EPS by 13c

Agios Pharm (NASDAQ: AGIO) reported Q2 EPS of ($0.54), $0.13 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $8.41 million versus the consensus estimate of $11 million.

For earnings history and earnings-related data on Agios Pharm (AGIO) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Schwab's May activity shows margin loans nearly double
• Sharon AI surges premarket; New Oriental gains, Medline slips